Pantoprazole and Reading disorder - a phase IV clinical study of FDA data

Summary:

Reading disorder is reported as a side effect among people who take Pantoprazole (pantoprazole sodium), especially for people who are female, 60+ old, also take Cymbalta, and have Pain.

The phase IV clinical study analyzes which people have Reading disorder when taking Pantoprazole. It is created by eHealthMe based on reports of 281,696 people who have side effects when taking Pantoprazole from the FDA, and is updated regularly.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,165 Pantoprazole users. Check the latest studies of Pantoprazole.

What is Reading disorder?

Reading disorder (problem in areas of the brain that help interpret language) is found to be associated with 298 drugs and 474 conditions by eHealthMe. Check the latest studies of Reading disorder.

On Jul, 11, 2026

281,696 people reported to have side effects when taking Pantoprazole.
Among them, 27 people (0.01%) have Reading disorder.

Could Pantoprazole cause Reading disorder?

Among these 27 people:

What is the gender of people who have Reading disorder when taking Pantoprazole? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Reading disorder when taking Pantoprazole? *

What are other drugs people take besides Pantoprazole? *

What are other side effects people have besides Reading disorder? *

Pain: 8 people, 29.63%
Fatigue (feeling of tiredness): 8 people, 29.63%
Memory Loss: 7 people, 25.93%
Disturbance In Attention: 6 people, 22.22%
Back Pain: 6 people, 22.22%
Weakness: 6 people, 22.22%
Vision Blurred: 6 people, 22.22%
Speech Disorder: 5 people, 18.52%
Nausea (feeling of having an urge to vomit): 5 people, 18.52%
Confusional State: 5 people, 18.52%

What are the existing conditions these people have? *

Pain: 6 people, 22.22%
High Blood Pressure: 5 people, 18.52%
Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 14.81%
Constipation: 3 people, 11.11%
Intervertebral Disc Protrusion (spinal disc protrusion): 3 people, 11.11%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 11.11%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 11.11%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 11.11%
Gastric Disorder (disease of stomach): 3 people, 11.11%
Fatigue (feeling of tiredness): 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole and have Reading disorder?

- Check whether Reading disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pantoprazole:

Pantoprazole (285,165 reports)

Browse all side effects of Pantoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Reading disorder:

Reading disorder (298 drugs)

Browse all the conditions that are associated with Reading disorder:

Reading disorder (474 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pantoprazole sodium (the active ingredients of Pantoprazole) and Pantoprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.